Immunocore Holdings PLC (NASDAQ: IMCR) is a clinical-stage biopharmaceutical company that develops T cell receptor-based therapies for the treatment of cancer and infectious diseases. The filing excerpts provided do not contain sufficient detail to describe its revenue model, approved products, commercial stage, geographic footprint, competitive position, leadership, or financial metrics. Based solely on the available excerpts, no further factual claims can be supported.

Source: SEC 10-K, filed 2026-02-25

Industry: Biological Products, (No Diagnostic Substances) Peers: Bicycle Therapeutics PLC Centessa Pharmaceuticals PLC Compass Pathways PLC Exscientia plc Myovant Sciences Ltd.